Skip to navigation menu Skip to content
High Priority Alert

View our masking and visitation guidelines based on current rates of respiratory illnesses in the community.

Harnessing the Power of the Immune System

Center for Immunity and Immunotherapies

Seattle Children’s is one of the few places in the world where bench-to-bedside immunology experts are both conducting research and providing treatment for more than 400 primary immune deficiency disorders.

Our teams have led over 20 clinical trials for patients with therapeutics discovered at Seattle Children’s Research Institute. We’re leading novel gene therapy clinical trials for pediatric disorders including X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, congenital neutropenia and severe combined immune deficiency. More than 75 immune diseases are actively managed by Seattle Children’s Immunology team.

As a world leader in gene therapy, our pioneering research could revolutionize treatment for hundreds of genetic disorders, curing disease at the source.

We also use gene editing to create regulatory T cells that calm the immune system in children with diabetes and other autoimmune diseases and in children who need organ transplants.

Building on our international reputation in CAR T cell therapies, we are designing next-generation therapeutics that focus on childhood brain cancers and solid tumors.

Seattle Children’s researchers are working toward a day where instead of kids getting lifelong treatments, they get a single infusion of cells that address a disease’s cause and cure it forever.

Center for Immunity and Immunotherapies

For questions or inquiries,

Physical Address

1920 Terry Ave.
Seattle, WA 98101

Mailing Address

PO Box 5371
Seattle, WA 98145-5005

By clicking “Accept All Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in marketing efforts. For more information, see Website Privacy.

Accept All Cookies